应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NCNA Nucana PLC
盘后交易 11-05 16:40:22 EST
1.53
-0.02
-1.29%
盘后
1.55
+0.02
+1.31%
16:36 EST
最高
1.60
最低
1.53
成交量
6.67万
今开
1.58
昨收
1.55
日振幅
4.52%
总市值
343.70万
流通市值
239.95万
总股本
224.64万
成交额
10.39万
换手率
4.25%
流通股本
156.83万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Nucana Plc盘中异动 股价大涨5.19%报1.62美元
市场透视 · 11-04 23:04
Nucana Plc盘中异动 股价大涨5.19%报1.62美元
Nucana Plc盘中异动 大幅跳水5.20%
市场透视 · 10-31
Nucana Plc盘中异动 大幅跳水5.20%
Nucana Plc盘中异动 快速下挫5.13%
市场透视 · 10-18
Nucana Plc盘中异动 快速下挫5.13%
Nucana Plc盘中异动 股价大涨5.95%报1.96美元
市场透视 · 10-17
Nucana Plc盘中异动 股价大涨5.95%报1.96美元
Nucana Plc盘中异动 早盘快速跳水5.64%报1.77美元
市场透视 · 10-16
Nucana Plc盘中异动 早盘快速跳水5.64%报1.77美元
Nucana Plc盘中异动 早盘快速跳水5.61%报2.02美元
市场透视 · 10-14
Nucana Plc盘中异动 早盘快速跳水5.61%报2.02美元
Nucana Plc盘中异动 下午盘大幅拉升5.21%报2.02美元
市场透视 · 10-09
Nucana Plc盘中异动 下午盘大幅拉升5.21%报2.02美元
Nucana Plc盘中异动 早盘股价大跌6.31%
市场透视 · 10-02
Nucana Plc盘中异动 早盘股价大跌6.31%
Nucana Plc盘中异动 股价大跌8.16%
市场透视 · 09-30
Nucana Plc盘中异动 股价大跌8.16%
Nucana Plc盘中异动 早盘股价大跌6.91%报2.56美元
市场透视 · 09-27
Nucana Plc盘中异动 早盘股价大跌6.91%报2.56美元
Nucana Plc盘中异动 早盘快速拉升8.36%
市场透视 · 09-26
Nucana Plc盘中异动 早盘快速拉升8.36%
Nucana Plc盘中异动 下午盘股价大涨5.88%
市场透视 · 09-25
Nucana Plc盘中异动 下午盘股价大涨5.88%
Nucana Plc盘中异动 临近午盘股价大涨5.36%
市场透视 · 09-19
Nucana Plc盘中异动 临近午盘股价大涨5.36%
NuCana(NCNA)涨近150% 转移性黑色素瘤相关治疗临床数据表现积极
金吾财讯 · 09-16
NuCana(NCNA)涨近150% 转移性黑色素瘤相关治疗临床数据表现积极
NuCana(NCNA)盘前暴涨近190% NUC-7738联合帕姆疟治疗黑色素瘤效果显著
金吾财讯 · 09-16
NuCana(NCNA)盘前暴涨近190% NUC-7738联合帕姆疟治疗黑色素瘤效果显著
Nucana Plc盘中异动 早盘股价大跌14.85%
自选股智能写手 · 08-20
Nucana Plc盘中异动 早盘股价大跌14.85%
Nucana Plc盘中异动 临近午盘大幅上涨7.14%
自选股智能写手 · 08-19
Nucana Plc盘中异动 临近午盘大幅上涨7.14%
Nucana Plc2024财年第二财季实现净利润-8.83百万美元,同比减少30.24%
自选股智能写手 · 08-19
Nucana Plc2024财年第二财季实现净利润-8.83百万美元,同比减少30.24%
Nucana Plc盘中异动 早盘股价大跌6.99%报3.06美元
自选股智能写手 · 08-16
Nucana Plc盘中异动 早盘股价大跌6.99%报3.06美元
Nucana Plc盘中异动 股价大涨5.01%报3.29美元
自选股智能写手 · 08-15
Nucana Plc盘中异动 股价大涨5.01%报3.29美元
加载更多
公司概况
公司名称:
Nucana PLC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nucana Plc是于1997年1月28日在英国和威尔士公司注册为英格兰和威尔士注册的名为以“生物医学”(英国)有限公司的私人公司。该公司是一个临床阶段的生物制药公司,致力于通过应用pro潮汐技术将一些最广泛的化疗制剂,核苷类似物转化为更有效和更安全的药物,从而显著提高癌症患者的治疗效果。虽然这些传统的药物仍然是治疗许多实体肿瘤的标准的一部分,但它们的效力受到癌症细胞抵抗机制的限制,而且它们通常是耐受不良的。利用他们的专利技术,他们正在开发新的药物,pro潮汐,旨在克服关键的癌症抵抗机制,并在癌细胞中产生更多的抗癌代谢物。
发行价格:
--
{"stockData":{"symbol":"NCNA","market":"US","secType":"STK","nameCN":"Nucana PLC","latestPrice":1.53,"timestamp":1730840400000,"preClose":1.55,"halted":0,"volume":66698,"hourTrading":{"tag":"盘后","latestPrice":1.55,"preClose":1.53,"latestTime":"16:36 EST","volume":578,"amount":906.2044684000001,"timestamp":1730842567693},"delay":0,"floatShares":1568272,"shares":2246400,"eps":-16.508324,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.02,"latestTime":"11-05 16:40:22 EST","open":1.58,"high":1.6,"low":1.53,"amount":103913.1895888,"amplitude":0.045161,"askPrice":1.58,"askSize":3,"bidPrice":1.53,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-16.508324,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1730854800000},"adr":1,"listingDate":1506571200000,"adjPreClose":1.55,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":1.6,"preClose":1.55,"latestTime":"09:16 EST","volume":80,"amount":128.4,"timestamp":1730816182768},"postHourTrading":{"tag":"盘后","latestPrice":1.55,"preClose":1.53,"latestTime":"16:36 EST","volume":578,"amount":906.2044684000001,"timestamp":1730842567693},"volumeRatio":0.523467},"requestUrl":"/m/hq/s/NCNA","defaultTab":"news","newsList":[{"id":"2480582741","title":"Nucana Plc盘中异动 股价大涨5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480582741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480582741?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:04","pubTimestamp":1730732697,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时04分,Nucana Plc股票出现异动,股价快速上涨5.19%。截至发稿,该股报1.62美元/股,成交量1.8497万股,换手率0.82%,振幅2.60%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.02%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230457971a42f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230457971a42f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2479752039","title":"Nucana Plc盘中异动 大幅跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479752039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479752039?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:36","pubTimestamp":1730385385,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时36分,Nucana Plc股票出现异动,股价大幅下跌5.20%。截至发稿,该股报1.64美元/股,成交量4.808万股,换手率2.14%,振幅4.34%。Nucana Plc股票所在的生物技术行业中,整体跌幅为3.14%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122362698e3fc02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122362698e3fc02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2476825202","title":"Nucana Plc盘中异动 快速下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476825202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476825202?lang=zh_cn&edition=full","pubTime":"2024-10-18 22:53","pubTimestamp":1729263181,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日22时53分,Nucana Plc股票出现波动,股价快速跳水5.13%。截至发稿,该股报1.85美元/股,成交量7.883万股,换手率3.51%,振幅6.15%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.31%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018225301ab6b31d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018225301ab6b31d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCNA"],"gpt_icon":0},{"id":"2476103094","title":"Nucana Plc盘中异动 股价大涨5.95%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476103094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476103094?lang=zh_cn&edition=full","pubTime":"2024-10-17 23:38","pubTimestamp":1729179503,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日23时38分,Nucana Plc股票出现波动,股价大幅上涨5.95%。截至发稿,该股报1.96美元/股,成交量9.911万股,换手率4.41%,振幅4.33%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.39%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017233823ab6add49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017233823ab6add49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCNA"],"gpt_icon":0},{"id":"2475599785","title":"Nucana Plc盘中异动 早盘快速跳水5.64%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475599785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475599785?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:32","pubTimestamp":1729085541,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时32分,Nucana Plc股票出现异动,股价大幅下跌5.64%。截至发稿,该股报1.77美元/股,成交量2.9812万股,换手率1.33%,振幅4.79%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.28%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213221971a09ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213221971a09ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2475988443","title":"Nucana Plc盘中异动 早盘快速跳水5.61%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475988443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475988443?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:57","pubTimestamp":1728914233,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时57分,Nucana Plc股票出现波动,股价快速下跌5.61%。截至发稿,该股报2.02美元/股,成交量3.107万股,换手率1.38%,振幅3.72%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.06%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014215713971a01ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014215713971a01ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2474402407","title":"Nucana Plc盘中异动 下午盘大幅拉升5.21%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474402407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474402407?lang=zh_cn&edition=full","pubTime":"2024-10-09 02:35","pubTimestamp":1728412542,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日02时35分,Nucana Plc股票出现异动,股价急速拉升5.21%。截至发稿,该股报2.02美元/股,成交量12.673万股,换手率5.64%,振幅7.78%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.41%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090235429719f06e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090235429719f06e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2472267685","title":"Nucana Plc盘中异动 早盘股价大跌6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472267685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472267685?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:37","pubTimestamp":1727876258,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时37分,Nucana Plc股票出现波动,股价大幅跳水6.31%。截至发稿,该股报1.93美元/股,成交量2.4924万股,换手率1.11%,振幅3.88%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.68%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100221373898e3a341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100221373898e3a341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCNA"],"gpt_icon":0},{"id":"2471855883","title":"Nucana Plc盘中异动 股价大跌8.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471855883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471855883?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:45","pubTimestamp":1727703944,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时45分,Nucana Plc股票出现异动,股价急速下挫8.16%。截至发稿,该股报2.25美元/股,成交量10.8806万股,换手率4.84%,振幅10.20%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.05%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302145449719d99a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302145449719d99a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2470086825","title":"Nucana Plc盘中异动 早盘股价大跌6.91%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470086825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470086825?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:34","pubTimestamp":1727444044,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时34分,Nucana Plc股票出现波动,股价急速下挫6.91%。截至发稿,该股报2.56美元/股,成交量9.0016万股,换手率4.01%,振幅6.99%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.57%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272134049581e3a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272134049581e3a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2470361732","title":"Nucana Plc盘中异动 早盘快速拉升8.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470361732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470361732?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:32","pubTimestamp":1727357549,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时32分,Nucana Plc股票出现波动,股价急速拉升8.36%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.39%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213229957f7993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213229957f7993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","NCNA","BK4139"],"gpt_icon":0},{"id":"2470241766","title":"Nucana Plc盘中异动 下午盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470241766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470241766?lang=zh_cn&edition=full","pubTime":"2024-09-25 01:23","pubTimestamp":1727198602,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日01时23分,Nucana Plc股票出现异动,股价大幅拉升5.88%。截至发稿,该股报3.42美元/股,成交量13.553万股,换手率6.03%,振幅8.67%。Nucana Plc股票所在的生物技术行业中,整体跌幅为1.04%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925012323a1dc3dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925012323a1dc3dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCNA"],"gpt_icon":0},{"id":"2468501719","title":"Nucana Plc盘中异动 临近午盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468501719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468501719?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:45","pubTimestamp":1726760709,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时45分,Nucana Plc股票出现异动,股价大幅拉升5.36%。截至发稿,该股报3.62美元/股,成交量16.5334万股,换手率7.36%,振幅8.72%。Nucana Plc股票所在的生物技术行业中,整体涨幅为1.23%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919234510a1db36bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919234510a1db36bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCNA"],"gpt_icon":1},{"id":"2467166845","title":"NuCana(NCNA)涨近150% 转移性黑色素瘤相关治疗临床数据表现积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2467166845","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467166845?lang=zh_cn&edition=full","pubTime":"2024-09-16 21:51","pubTimestamp":1726494716,"startTime":"0","endTime":"0","summary":"金吾财讯 | NuCana(NCNA)早盘强势,截止发稿,涨147.24%,报6.28美元。消息面上,公司在欧洲肿瘤内科学会(ESMO)大会上展示了其2期临床研究NuTide:701的最终数据,该研究评估了NUC-7738与帕姆疟(pembrolizumab)联合用于对PD-1偶联治疗无效或突变的转移性黑色素瘤患者。在这12名患者的研究组中,大多数患者已接受过至少两轮PD-1复发治疗,其中9名患者(75%)实现了疾病控制,其中2名患者取得了部分缓解(部分反应)。奥本海默控股维持公司买入评级及目标价25美元。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279947","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NCNA"],"gpt_icon":0},{"id":"2467819210","title":"NuCana(NCNA)盘前暴涨近190% NUC-7738联合帕姆疟治疗黑色素瘤效果显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2467819210","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467819210?lang=zh_cn&edition=full","pubTime":"2024-09-16 19:32","pubTimestamp":1726486341,"startTime":"0","endTime":"0","summary":"金吾财讯 | NuCana 盘前股价飙升,暂涨189.37%,报7.36美元。消息面上,公司在欧洲肿瘤内科学会大会上展示了其2期临床研究NuTide:701的最终数据,该研究评估了NUC-7738与帕姆疟联合用于对PD-1偶联治疗无效或突变的转移性黑色素瘤患者。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279934","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2460001471","title":"Nucana Plc盘中异动 早盘股价大跌14.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460001471","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460001471?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:31","pubTimestamp":1724160681,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时31分,Nucana Plc股票出现波动,股价大幅跳水14.85%。截至发稿,该股报8.26美元/股,成交量14.3931万股,换手率6.41%,振幅3.40%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.03%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021312195ab00cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021312195ab00cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0},{"id":"2460056125","title":"Nucana Plc盘中异动 临近午盘大幅上涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460056125","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460056125?lang=zh_cn&edition=full","pubTime":"2024-08-19 23:36","pubTimestamp":1724081766,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日23时36分,Nucana Plc股票出现异动,股价大幅上涨7.14%。截至发稿,该股报3.75美元/股,成交量3.7699万股,换手率1.68%,振幅6.43%。Nucana Plc股票所在的生物技术行业中,整体涨幅为1.33%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081923360798e35627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081923360798e35627&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NCNA","ALZN","BK4139"],"gpt_icon":0},{"id":"2460717239","title":"Nucana Plc2024财年第二财季实现净利润-8.83百万美元,同比减少30.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717239","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717239?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:05","pubTimestamp":1723997143,"startTime":"0","endTime":"0","summary":"8月19日,Nucana Plc公布财报,公告显示公司2024财年第二财季净利润为-8.83百万美元,同比减少30.24%;其中营业收入为0.00美元,每股基本收益为-3.89美元。从资产负债表来看,Nucana Plc总负债20.57百万美元,其中短期债务160540.70美元,资产负债比为1.24,流动比率为1.09。机构评级:截至2024年8月19日,当前有2家机构对Nucana Plc目标价做出预测,其中目标均价为151.27美元,其中最低目标价为149.98美元,最高目标价为152.55美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900055495a38786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900055495a38786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA"],"gpt_icon":0},{"id":"2459214216","title":"Nucana Plc盘中异动 早盘股价大跌6.99%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459214216","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459214216?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:33","pubTimestamp":1723815192,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时33分,Nucana Plc股票出现波动,股价快速下挫6.99%。截至发稿,该股报3.06美元/股,成交量1348股,换手率0.06%,振幅0.27%。Nucana Plc股票所在的生物技术行业中,整体跌幅为0.29%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621331298e352bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621331298e352bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","NCNA","BK4007","BK4139"],"gpt_icon":1},{"id":"2459476074","title":"Nucana Plc盘中异动 股价大涨5.01%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476074","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476074?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:44","pubTimestamp":1723733065,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时44分,Nucana Plc股票出现异动,股价快速拉升5.01%。截至发稿,该股报3.29美元/股,成交量3205股,换手率0.14%,振幅3.83%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.93%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522442597198d5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522442597198d5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nucana.com","stockEarnings":[{"period":"1week","weight":-0.1193},{"period":"1month","weight":-0.2172},{"period":"3month","weight":-0.5468},{"period":"6month","weight":-0.5777},{"period":"1year","weight":-0.8681},{"period":"ytd","weight":-0.7904}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nucana Plc是于1997年1月28日在英国和威尔士公司注册为英格兰和威尔士注册的名为以“生物医学”(英国)有限公司的私人公司。该公司是一个临床阶段的生物制药公司,致力于通过应用pro潮汐技术将一些最广泛的化疗制剂,核苷类似物转化为更有效和更安全的药物,从而显著提高癌症患者的治疗效果。虽然这些传统的药物仍然是治疗许多实体肿瘤的标准的一部分,但它们的效力受到癌症细胞抵抗机制的限制,而且它们通常是耐受不良的。利用他们的专利技术,他们正在开发新的药物,pro潮汐,旨在克服关键的癌症抵抗机制,并在癌细胞中产生更多的抗癌代谢物。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.425254},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.089764},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.055639},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.118795},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.072161},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.111663},{"month":7,"riseRate":0.571429,"avgChangeRate":0.237023},{"month":8,"riseRate":0.571429,"avgChangeRate":0.032293},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.157252},{"month":10,"riseRate":0,"avgChangeRate":-0.172934},{"month":11,"riseRate":0.5,"avgChangeRate":0.017039},{"month":12,"riseRate":0,"avgChangeRate":-0.195592}],"exchange":"NASDAQ","name":"Nucana PLC","nameEN":"Nucana PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nucana PLC(NCNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nucana PLC(NCNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nucana PLC,NCNA,Nucana PLC股票,Nucana PLC股票老虎,Nucana PLC股票老虎国际,Nucana PLC行情,Nucana PLC股票行情,Nucana PLC股价,Nucana PLC股市,Nucana PLC股票价格,Nucana PLC股票交易,Nucana PLC股票购买,Nucana PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nucana PLC(NCNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nucana PLC(NCNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}